Dandan Wang

机构：Nanjing University of Chinese Medicine, Nanchang University, Linyi University, Chinese Academy of Sciences, Peking University, Hefei Institutes of Physical Science, Zhengzhou University, First Affiliated Hospital of Jiangxi Medical College, Second Affiliated Hospital of Nanchang University, Nanjing Drum Tower Hospital, Third Affiliated Hospital of Nanchang University, Henan Cancer Hospital, Henan Institute of Science and Technology, Henan Medical University, Nanjing Medical University · ORCID：0000-0002-1926-9128

发表论文 77 篇 · 总被引 2151 次 · h-index 26

代表论文

• TPI1 activates the PI3K/AKT/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5 (2022 · Journal of Translational Medicine · 被引 93)
• Surface Molecularly Engineered Mitochondria Conduct Immunophenotype Repolarization of Tumor‐Associated Macrophages to Potentiate Cancer Immunotherapy (2024 · Advanced Science · 被引 34)
• Exosomal microRNAs shuttling between tumor cells and macrophages: cellular interactions and novel therapeutic strategies (2022 · Cancer Cell International · 被引 19)
• circNFIB decreases synthesis of arachidonic acid and inhibits breast tumor growth and metastasis (2023 · European Journal of Pharmacology · 被引 12)
• Expression profile and prognostic values of SMC family members in HCC (2022 · Medicine · 被引 11)
• Inhibition of TPI1 Sensitizes Cisplatin-Resistant Oral Cancer to Ferroptosis (2025 · Biomedicines · 被引 10)